The rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure was reduced by a high doses of a popular cholesterol-lowering drug. This is according to a research presented at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests. Previous studies have demonstrated ...
View the Original article
